Form 8-K - Current report:
SEC Accession No. 0001193125-19-212979
Filing Date
2019-08-05
Accepted
2019-08-05 16:15:02
Documents
3
Period of Report
2019-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d788032d8k.htm 8-K 18740
2 EX-99.1 d788032dex991.htm EX-99.1 49187
3 GRAPHIC g788032g0805223338782.jpg GRAPHIC 3726
  Complete submission text file 0001193125-19-212979.txt   74307
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 19998797
SIC: 2834 Pharmaceutical Preparations